$2.67 Billion is the total value of PFM Health Sciences, LP's 68 reported holdings in Q1 2022. The portfolio turnover from Q4 2021 to Q1 2022 was 32.4% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| OM | Sell | OUTSET MED INC | $127,605,000 | -5.8% | 2,810,686 | -4.4% | 4.77% | +3.4% |
| HZNP | HORIZON THERAPEUTICS PUB L | $114,872,000 | -2.4% | 1,091,840 | 0.0% | 4.30% | +7.2% | |
| RCUS | ARCUS BIOSCIENCES INC | $108,283,000 | -22.0% | 3,431,010 | 0.0% | 4.05% | -14.4% | |
| JNJ | Buy | JOHNSON & JOHNSON | $103,659,000 | +86.5% | 584,883 | +80.0% | 3.88% | +104.8% |
| CNC | CENTENE CORP DEL | $93,660,000 | +2.2% | 1,112,480 | 0.0% | 3.50% | +12.2% | |
| CYTK | CYTOKINETICS INC | $90,737,000 | -19.2% | 2,465,016 | 0.0% | 3.39% | -11.3% | |
| LLY | LILLY ELI & CO | $85,522,000 | +3.7% | 298,643 | 0.0% | 3.20% | +13.8% | |
| New | GILEAD SCIENCES INCcall | $83,973,000 | – | 1,412,500 | +100.0% | 3.14% | – | |
| JAZZ | New | JAZZ PHARMACEUTICALS PLC | $80,389,000 | – | 516,406 | +100.0% | 3.01% | – |
| IRTC | Sell | IRHYTHM TECHNOLOGIES INC | $77,746,000 | +26.1% | 493,721 | -5.8% | 2.91% | +38.4% |
| HUM | Buy | HUMANA INC | $72,267,000 | +11.7% | 166,066 | +19.1% | 2.70% | +22.7% |
| AVTR | AVANTOR INC | $70,334,000 | -19.7% | 2,079,657 | 0.0% | 2.63% | -11.9% | |
| PFE | PFIZER INC | $69,547,000 | -12.3% | 1,343,384 | 0.0% | 2.60% | -3.7% | |
| UHS | Sell | UNIVERSAL HLTH SVCS INCcl b | $63,972,000 | +3.8% | 441,336 | -7.2% | 2.39% | +14.0% |
| UNH | UNITEDHEALTH GROUP INC | $56,889,000 | +1.6% | 111,554 | 0.0% | 2.13% | +11.5% | |
| BMRN | Buy | BIOMARIN PHARMACEUTICAL INC | $55,396,000 | +34.9% | 718,495 | +54.5% | 2.07% | +48.0% |
| DHR | DANAHER CORPORATION | $51,535,000 | -10.8% | 175,690 | 0.0% | 1.93% | -2.1% | |
| IQV | Sell | IQVIA HLDGS INC | $51,258,000 | -23.7% | 221,696 | -6.9% | 1.92% | -16.2% |
| ICUI | ICU MED INC | $49,111,000 | -6.2% | 220,587 | 0.0% | 1.84% | +3.0% | |
| MOH | Buy | MOLINA HEALTHCARE INC | $47,963,000 | +115.1% | 143,779 | +105.1% | 1.79% | +136.2% |
| MYGN | Sell | MYRIAD GENETICS INC | $47,435,000 | -15.2% | 1,882,357 | -7.1% | 1.77% | -6.8% |
| NVRO | Buy | NEVRO CORP | $46,979,000 | +19.4% | 649,513 | +33.9% | 1.76% | +31.2% |
| THC | Buy | TENET HEALTHCARE CORP | $46,812,000 | +9.0% | 544,583 | +3.5% | 1.75% | +19.6% |
| BIOMARIN PHARMACEUTICAL INCnote 0.599% 8/0 | $46,002,000 | -4.4% | 45,910,000 | 0.0% | 1.72% | +5.0% | ||
| AERIE PHARMACEUTICALS INCnote 1.500%10/0 | $43,919,000 | +9.1% | 48,150,000 | 0.0% | 1.64% | +19.8% | ||
| BDX | New | BECTON DICKINSON & CO | $41,920,000 | – | 157,593 | +100.0% | 1.57% | – |
| DVAX | DYNAVAX TECHNOLOGIES CORP | $41,250,000 | -23.0% | 3,805,370 | 0.0% | 1.54% | -15.4% | |
| Sell | ERASCA INC | $41,206,000 | -46.5% | 4,791,406 | -7.7% | 1.54% | -41.2% | |
| Buy | CARIBOU BIOSCIENCES INC | $40,122,000 | -32.5% | 4,370,545 | +6.8% | 1.50% | -25.9% | |
| EW | Sell | EDWARDS LIFESCIENCES CORP | $39,808,000 | -17.7% | 338,155 | -9.5% | 1.49% | -9.6% |
| ICLR | ICON PLC | $38,473,000 | -21.5% | 158,183 | 0.0% | 1.44% | -13.7% | |
| PEN | Sell | PENUMBRA INC | $37,033,000 | -27.2% | 166,719 | -5.9% | 1.38% | -20.0% |
| TMO | THERMO FISHER SCIENTIFIC INC | $36,705,000 | -11.5% | 62,143 | 0.0% | 1.37% | -2.8% | |
| WAT | WATERS CORP | $36,512,000 | -16.7% | 117,634 | 0.0% | 1.36% | -8.5% | |
| CAH | CARDINAL HEALTH INC | $36,276,000 | +10.1% | 639,783 | 0.0% | 1.36% | +20.9% | |
| SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $35,514,000 | -22.9% | 2,043,377 | -2.9% | 1.33% | -15.3% |
| SRRA | New | SIERRA ONCOLOGY INC | $34,066,000 | – | 1,062,888 | +100.0% | 1.27% | – |
| MCK | Sell | MCKESSON CORP | $32,392,000 | -26.4% | 105,811 | -40.2% | 1.21% | -19.2% |
| AZN | Sell | ASTRAZENECA PLCsponsored adr | $30,006,000 | -34.4% | 452,300 | -42.4% | 1.12% | -28.0% |
| CTLT | Sell | CATALENT INC | $28,401,000 | -32.1% | 256,096 | -21.6% | 1.06% | -25.4% |
| JNCE | JOUNCE THERAPEUTICS INC | $26,976,000 | -18.7% | 3,972,868 | 0.0% | 1.01% | -10.6% | |
| KRTX | Buy | KARUNA THERAPEUTICS INC | $26,260,000 | +13.2% | 207,116 | +17.0% | 0.98% | +24.3% |
| CI | New | CIGNA CORP NEW | $22,556,000 | – | 94,135 | +100.0% | 0.84% | – |
| ANTM | ANTHEM INC | $20,992,000 | +6.0% | 42,734 | 0.0% | 0.78% | +16.5% | |
| NTLA | Buy | INTELLIA THERAPEUTICS INC | $20,922,000 | -0.7% | 287,909 | +61.5% | 0.78% | +9.1% |
| HCA | Sell | HCA HEALTHCARE INC | $20,082,000 | -60.0% | 80,128 | -59.0% | 0.75% | -56.1% |
| HRTX | HERON THERAPEUTICS INC | $20,091,000 | -37.3% | 3,512,348 | 0.0% | 0.75% | -31.2% | |
| DXCM | Buy | DEXCOM INC | $18,940,000 | +689.2% | 37,021 | +728.4% | 0.71% | +763.4% |
| ISEE | IVERIC BIO INC | $16,918,000 | +0.7% | 1,005,216 | 0.0% | 0.63% | +10.7% | |
| Buy | SOPHIA GENETICS SAordinary shares | $15,568,000 | -43.4% | 2,014,024 | +3.2% | 0.58% | -37.9% | |
| GILD | Buy | GILEAD SCIENCES INC | $14,856,000 | +165.8% | 249,884 | +224.6% | 0.56% | +192.6% |
| OSH | Buy | OAK STR HEALTH INC | $14,076,000 | +52.0% | 523,644 | +87.4% | 0.53% | +67.0% |
| AERI | AERIE PHARMACEUTICALS INC | $9,906,000 | +29.6% | 1,088,566 | 0.0% | 0.37% | +42.3% | |
| QURE | New | UNIQURE NV | $9,661,000 | – | 534,624 | +100.0% | 0.36% | – |
| PMVP | Buy | PMV PHARMACEUTICALS INC | $9,292,000 | +39.5% | 446,300 | +54.8% | 0.35% | +52.9% |
| PRAX | Buy | PRAXIS PRECISION MEDICINES I | $8,830,000 | -29.5% | 864,819 | +36.0% | 0.33% | -22.7% |
| VERV | New | VERVE THERAPEUTICS INC | $8,438,000 | – | 369,765 | +100.0% | 0.32% | – |
| CANO | Sell | CANO HEALTH INC | $8,267,000 | -51.5% | 1,301,937 | -32.0% | 0.31% | -46.8% |
| CCCC | New | C4 THERAPEUTICS INC | $6,909,000 | – | 284,772 | +100.0% | 0.26% | – |
| IO BIOTECH INC | $6,649,000 | -14.1% | 1,362,144 | 0.0% | 0.25% | -5.7% | ||
| Buy | PARDES BIOSCIENCES INC | $5,273,000 | -10.9% | 730,357 | +102.0% | 0.20% | -2.0% | |
| ADAP | Sell | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $4,892,000 | -59.2% | 2,374,674 | -25.8% | 0.18% | -55.3% |
| JYAC | JIYA ACQUISITION CORP | $4,562,000 | +0.6% | 464,103 | 0.0% | 0.17% | +11.0% | |
| BLSA | BCLS ACQUISITION CORP | $4,581,000 | +0.7% | 464,103 | 0.0% | 0.17% | +10.3% | |
| GBIO | New | GENERATION BIO CO | $4,215,000 | – | 574,278 | +100.0% | 0.16% | – |
| FLDM | FLUIDIGM CORP DEL | $3,520,000 | -8.4% | 980,505 | 0.0% | 0.13% | +0.8% | |
| SANA | New | SANA BIOTECHNOLOGY INC | $2,935,000 | – | 355,272 | +100.0% | 0.11% | – |
| HOWL | Buy | WEREWOLF THERAPEUTICS INC | $2,575,000 | -45.9% | 585,327 | +46.3% | 0.10% | -40.7% |
| ALNA | Exit | ALLENA PHARMACEUTICALS | $0 | – | -284,285 | -100.0% | -0.01% | – |
| Exit | PROCEPT BIOROBOTICS CORP | $0 | – | -65,000 | -100.0% | -0.06% | – | |
| KNTE | Exit | KINNATE BIOPHARMA INC | $0 | – | -264,293 | -100.0% | -0.16% | – |
| LUNG | Exit | PULMONX CORP | $0 | – | -209,193 | -100.0% | -0.23% | – |
| INCY | Exit | INCYTE CORP | $0 | – | -129,428 | -100.0% | -0.32% | – |
| BFLY | Exit | BUTTERFLY NETWORK INC | $0 | – | -1,828,311 | -100.0% | -0.42% | – |
| NVAX | Exit | NOVAVAX INC | $0 | – | -88,663 | -100.0% | -0.43% | – |
| Exit | SPDR SER TRcall | $0 | – | -246,100 | -100.0% | -0.94% | – | |
| NBIX | Exit | NEUROCRINE BIOSCIENCES INC | $0 | – | -394,058 | -100.0% | -1.14% | – |
| SGEN | Exit | SEAGEN INC | $0 | – | -268,527 | -100.0% | -1.41% | – |
| Exit | ISHARES TRcall | $0 | – | -272,800 | -100.0% | -1.42% | – | |
| MRTX | Exit | MIRATI THERAPEUTICS INC | $0 | – | -315,449 | -100.0% | -1.58% | – |
| ABBV | Exit | ABBVIE INC | $0 | – | -916,496 | -100.0% | -4.22% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2022-05-16
Signatures
The EDGAR filing(s) were signed by:
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| MOLINA HEALTHCARE INC | 41 | Q3 2023 | 2.2% |
| HCA HOLDINGS INC | 38 | Q3 2023 | 5.2% |
| HUMANA INC | 37 | Q3 2023 | 3.8% |
| EDWARDS LIFESCIENCES CORP | 36 | Q3 2023 | 3.3% |
| UNITEDHEALTH GROUP INC | 33 | Q3 2023 | 4.8% |
| PENUMBRA INC | 33 | Q3 2023 | 4.8% |
| AERIE PHARMACEUTICALS INC | 28 | Q2 2022 | 3.7% |
| TENET HEALTHCARE CORP | 27 | Q3 2023 | 2.3% |
| ELEVANCE HEALTH INC | 26 | Q3 2023 | 4.2% |
| ICON PLC | 26 | Q3 2023 | 2.5% |
View PFM Health Sciences, LP's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Adaptimmune Therapeutics PLC | February 14, 2023 | ? | ? |
| Arcus Biosciences, Inc. | February 14, 2023 | ? | ? |
| Axsome Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Erasca, Inc. | February 14, 2023 | ? | ? |
| Generation Bio Co. | February 14, 2023 | ? | ? |
| IO Biotech, Inc. | February 14, 2023 | ? | ? |
| Jounce Therapeutics, Inc. | February 14, 2023 | ? | ? |
| Outset Medical, Inc. | February 14, 2023 | ? | ? |
| uniQure N.V. | February 14, 2023 | ? | ? |
| AERIE PHARMACEUTICALS INC | February 14, 2022 | ? | ? |
View PFM Health Sciences, LP's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| SC 13G | 2023-04-21 |
View PFM Health Sciences, LP's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.